We have received text from S. 5724: Protecting Approved Care Act. This bill was received on 2026-11-17, and currently has 1 cosponsor.
Here is a short summary of the bill:
This bill would change how Medicare Advantage plans can use prior authorization and claims denials, starting with plan years on or after January 1, 2028.
What it would do
If a Medicare Advantage plan has already approved a patient’s care through a prior authorization, preservice determination, or similar approval made while the patient is receiving care, the plan generally could not later reverse that decision for that same item or service. If the plan did not require prior authorization at all for a covered item or service, it also could not later deny payment after the patient has already received it, based on the same kinds of post-service review.
Limits on later denials and changes
The bill would prohibit Medicare Advantage organizations from doing three main things after approving or allowing care:
- Denying coverage later on the ground that the service was not medically necessary.
- Reopening an approval or payment decision, except for limited reasons such as good cause or reliable evidence of fraud or similar fault.
- Changing the billing code in a way that reduces payment, except in cases involving good cause or fraud/similar fault.
What counts as “specified authorization”
The bill defines this term broadly to include:
- Prior authorization;
- Preservice determinations of coverage or payment; and
- Concurrent decisions made while the patient is already receiving the service.
It also includes approvals for transfers between hospitals, or between a hospital and a post-acute care facility.
Practical effect
In plain terms, the bill would make it harder for Medicare Advantage plans to approve care first and then later reject payment or reduce payment for that same care, except in limited situations like fraud or certain regulatory exceptions. The goal is to give approved care more finality once it has been authorized or provided.
Relevant Companies
- UNH - UnitedHealth Group, through its UnitedHealthcare Medicare Advantage business, could be directly affected by tighter limits on later denials, payment reversals, and coding changes.
- HUM - Humana is a major Medicare Advantage insurer and could be affected by restrictions on post-approval claim denials and reopening of coverage decisions.
- CNC - Centene operates Medicare Advantage plans and could be impacted by the bill’s limits on prior authorization-based denials and payment adjustments.
- ELV - Elevance Health has Medicare Advantage exposure and could be affected by changes to how approved services can later be denied or repriced.
- CI - The Cigna Group, through its health plan operations, could be affected if its Medicare Advantage-related claims review practices are constrained by this bill.
Senator John Kennedy Bill Proposals
Here are some bills which have recently been proposed by Senator John Kennedy:
- S.5820: A bill to establish Governmentwide requirements for pre-payment fraud prevention actions, to provide the U.S. Treasury appropriate data resources, to facilitate participation in Governmentwide anti-fraud data sharing, and for other purposes.
- S.5724: Protecting Approved Care Act
- S.5628: Transparency in CFPB Cost-Benefit Analysis Act
- S.5487: TWICE Act
- S.5423: Support Our Educators Act of 2026
- S.5417: AI Emergency Button Act
You can track bills proposed by Senator John Kennedy on Quiver Quantitative's politician page for Kennedy.
Senator John Kennedy Net Worth
Quiver Quantitative estimates that Senator John Kennedy is worth $20.3M, as of November 21st, 2026. This is the 62nd highest net worth in Congress, per our live estimates.
Kennedy has approximately $6.0M invested in publicly traded assets which Quiver is able to track live.
You can track Senator John Kennedy's net worth on Quiver Quantitative's politician page for Kennedy.
Senator John Kennedy Stock Trading
We have data on up to $45.0K of trades from Senator John Kennedy, which we parsed from STOCK Act filings. Some of the largest trades include:
- A October 11th, 2018 purchase of up to $15K of $MTUM. The stock has risen 123.1% since then.
You can track Senator John Kennedy's stock trading on Quiver Quantitative's politician page for Kennedy.
2028 Louisiana US Senate Election
There has been approximately $82,672,877 of spending in Louisiana US Senate elections over the last two years, per our estimates.
Approximately $28,352,067 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:
- LOUISIANA FREEDOM FUND ($10,816,740)
- ACCOUNTABILITY PROJECT INC ($10,715,693)
- AMERICAN MISSION ($1,173,385)
- CONSERVATIVES FOR AMERICAN EXCELLENCE INC. ($1,163,258)
- SAVE AMERICAN FREEDOM ($963,442)
The rating for this race is currently "Solid R".
You can track this election on our matchup page for the 2028 Louisiana US Senate election.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.